Vietri Jeffrey, Burslem Kate, Su Jun
From the Health Outcomes Practice (Dr Vietri), Kantar Health, Princeton, NJ; and Boehringer Ingelheim Pharmaceuticals, Inc (Mr Burslem and Dr Su), Ridgefield, Conn.
J Occup Environ Med. 2014 Apr;56(4):425-30. doi: 10.1097/JOM.0000000000000123.
This study examined the impact of asthma control on health-related outcomes among employed US asthma sufferers treated with prescription medicines.
Data from the 2011 National Health and Wellness Survey (N = 75,000) were used. The Asthma Control Test, validated measures of health-related quality of life, work productivity and activity impairment, and questions assessing health care use were included.
Of the 2026 employed asthma sufferers treated with prescription medicines included, 39.7% had Asthma Control Test scores indicating poorly controlled asthma. After adjusting for covariates, workers with poorly controlled asthma had worse health-related quality of life, work and activity impairment, and more health care use than those with well-controlled asthma.
Poorly controlled asthma in employed patients treated with prescription medicines is common, and associated with negative health outcomes. Workers, employers, and payers could all benefit from improvements in asthma control.
本研究调查了在美国,使用处方药治疗的在职哮喘患者中,哮喘控制情况对健康相关结果的影响。
采用2011年国民健康与健康状况调查的数据(N = 75,000)。其中包括哮喘控制测试、经过验证的健康相关生活质量、工作效率和活动障碍的测量指标,以及评估医疗保健使用情况的问题。
在纳入的2026名使用处方药治疗的在职哮喘患者中,39.7%的哮喘控制测试得分表明哮喘控制不佳。在对协变量进行调整后,哮喘控制不佳的患者与哮喘控制良好的患者相比,其健康相关生活质量更差,工作和活动受限更严重,医疗保健使用也更多。
使用处方药治疗的在职患者中,哮喘控制不佳的情况很常见,且与不良健康结果相关。员工、雇主和医保支付方都能从改善哮喘控制中受益。